Status:
UNKNOWN
The Protective Effects of Sevoflurane in Pediatric Cardiac Surgery
Lead Sponsor:
Xijing Hospital
Conditions:
Congenital Heart Diseases
Eligibility:
All Genders
1-24 years
Phase:
NA
Brief Summary
During repair of a congenital heart defect the child is exposed to myocardial hypoxia. Recent studies have suggested that the paediatric myocardium is more sensitive to hypoxia and cardioplegic arrest...
Eligibility Criteria
Inclusion
- pediatric patients (body weight \< 10 kg)
- diagnosed with congenital heart diseases
- scheduled for repair operation with CPB
- in the Department of Cardiovascular Surgery, Xijing Hospital
Exclusion
- systemic infections
- other systemic diseases
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2012
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01450956
Start Date
September 1 2011
End Date
January 1 2012
Last Update
November 28 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Cardiovascular Surgery, Xijing Hospital
Xi'an, Shaanxi, China, 710032